Project Grant R61DA064827
- The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Pittsburgh a $188,307 Project Grant, effective September 1, 2025, through August 31, 2029, under the Drug Use and Addiction Research Programs (CFDA 93.279). Led by Principal Investigator Dr. Edwards, this initiative will develop a guided, web-based behavioral treatment intervention combining Acceptance and Commitment Therapy (ACT) for chronic pain and Mindfulness-Based Relapse Prevention (MBRP)...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The University of Kentucky Research Foundation a $422,921 Project Grant on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test the STAR (Support Towards Addiction Recovery) intervention. This dyadic intervention is designed to improve recovery outcomes for individuals with substance use disorder (SUD) who have involvement in the criminal legal system (CLS) by...
- Federal Project Grant Award Summary Columbia University received a $1,000,028 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025 through August 31, 2027. The award funds an R61/R33 effectiveness trial of WINGS+++ (Women Initiating New Goals of Safety), a mobile health intervention designed to address the intersection of opioid use disorder (OUD), substance use disorders (SUD), intimate...
- Federal Grant Award Summary New York University School of Medicine received a $1.45M Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective July 1, 2025 through March 31, 2030. The award supports a population-based data linkage study characterizing complex opioid use disorder (OUD) care trajectories and outcomes following acute service utilization. The research will examine patients experiencing...
- Federal Grant Award Summary Duke University received a $363,362 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2030. The award supports the development and testing of behavioral intervention protocols designed to address post-incarceration substance use and related health outcomes among individuals with opioid use disorders. The research initiative integrates evidence-based...
- Federal Grant Award Summary The University of Pittsburgh received a $378,963 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) for research addressing cardiovascular disease (CVD) prevention among people with opioid use disorder (OUD). The project, initiated April 15, 2025, and continuing through March 31, 2030, will deliver evidence-based research examining the relationship between CVD and OUD and evaluating the...
- Federal Grant Award Summary Rutgers, The State University received a $2.56M Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded June 1, 2025, with an ultimate completion date of February 28, 2029. The grant funds meta-analysis of individual patient data (MIPD) research to identify clinically significant trajectories and recovery outcomes for individuals with co-occurring posttraumatic stress disorder (PTSD) and...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Research Triangle Institute (RTI International) a $1,985,550 Project Grant on September 30, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a hybrid Type I randomized controlled trial assessing the effectiveness of a peer-led court navigation intervention for facilitating linkage to substance use disorder (SUD) treatment. The award extends through May 31, 2030, and will test...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $742,500 Project Grant (R34) to Massachusetts General Hospital on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This three-year pilot study, concluding June 30, 2028, will develop and test a peer recovery coaching intervention designed to promote tobacco abstinence in individuals with concurrent opioid use disorder and tobacco use disorder (MOUD-TUD). The project will adapt an...
The University of Rochester received a $433,029 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and pilot a novel couples-based treatment intervention for dual substance use disorder (DUD) in heterosexual couples. The award, effective March 15, 2026 through February 28, 2028, addresses a critical gap in addiction treatment by creating a specialized intervention tailored to couples where both partners misuse opioids and/or stimulants. The intervention development employs a co-creation approach engaging affected couples, treatment providers, and administrators to ensure stakeholder-informed design. The research project follows a phased R61/R33 structure integrating the Intervention Mapping + ADAPT (IMA) framework for intervention development with the Consolidated Framework for Implementation Research (CFIR) to guide implementation strategies. The R61 phase will conduct formative mixed-methods research to identify key determinants and recovery assets influencing drug use behavior and treatment outcomes among dual-DUD couples, grounded in the Recovery Capital Framework and the Substance Use Disorder Couple System Model. This research directly responds to evidence demonstrating that 30-50% of individuals with DUDs have partners with concurrent DUDs, yet current treatment paradigms remain predominantly individual-focused despite documented reciprocal influence between partners on substance use outcomes and recovery trajectories.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $433.0k | 3/5/26 |